Replication data for: Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020

The dataset was generated from members of randomly selected households from an existing population-based infectious disease surveillance (PBIDS) who participated in a serosurvey. The participated provided blood specimens between 27th November and 5th December 2020 after consenting. The specimens were tested for antibodies to the SARS-CoV-2 spike protein using the Wantai SARS-CoV-2 two-step antigen sandwich enzyme immunoassay kit (Wantai Biological Pharmacy Enterprise Ltd, Beijing, China).